This satellite symposium will feature an engaging presentation on the potential causes of neurotrophic keratitis, how to differentiate it from similar diseases, and when referrals may be necessary. Treatment options will also be discussed, including the mechanisms of action of newer therapies and when they should be introduced.
This presentation will be followed by case discussions and audience question-and-answer session.
Supported by an unrestricted educational grant from Dompé.
Upon completion of this activity, the participant should be able to:
Credit Designation Statement
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This activity, COPE Activity Number 122691, is accredited by COPE for continuing education for optometrists.
This course is approved for 1.5 hours of CE.
Course #75011-AS
Activity #122691
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Kelly K. Nichols, OD, MPH, PhD, FAAO
Program Chair
Professor and Dean
University of Alabama at Birmingham School of Optometry
Birmingham, AL
Scott Hauswirth, OD, FAAO
Assistant Professor
University of Colorado
Anschutz Medical Campus
Aurora, CO
Walter O. Whitley, OD, MBA, FAAO
Director of Optometric Services
Virginia Eye Consultants
Norfolk, VA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Kelly K. Nichols, OD, MPH, PhD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bruder, Dompé, HanAll Bio, Kala Pharmaceuticals, Novartis, Osmotica, Oyster Point Pharma, Sight Sciences, Tarsis, Thea, and Topivent. Grant/Research: Allergan, Kala Pharmaceuticals, NIH, and Tear Science. Stock/Shareholder: Acquiom, Alcon Vision, LacriScience, and Tear Film Innovations.
Scott Hauswirth, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: BioTissue, Eyevance, Glaukos, Horizon, Kala Pharmaceuticals, NuSight Medical, Science Based Health, and Sight Sciences. Grant/Research Support: Claris Biotherapeutics, Dompé, NiCox, Ocular Therapeutix, Oyster Point Pharma, and Sylentis. Speakers List: Kala Pharmaceuticals. Shareholder: Horizon and Oyster Point Pharma.
Walter O. Whitley, OD, MBA, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon Vision, Allergan, Bausch + Lomb, Bio-Tissue, Bruder Healthcare, Eyevance, Glaukos, Horizon Therapeutics, Johnson & Johnson Vision, Kala Pharmaceuticals, Notal Vision, Novartis, Ocular Therapeutix, Ocusoft, Oyster Point Pharma, Quidel, Regener-Eyes, RVL Pharmaceuticals, ScienceBased Health, Sun Pharmaceutical Industries, Tarsus Pharmaceuticals, TearLab, and Thea Pharmaceuticals. Speaker’s Bureau: Aerie Pharmaceuticals, Alcon Vision, Bausch + Lomb, Bio-Tissue, Eyevance, Novartis, ScienceBased Health, and Sun Pharmaceutical Industries. Share/Stockholder: Leo Lens Technology.
The Evolve staff and planners have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Dompé.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Justis P. Ehlers, MD, FASRS
Roger A. Goldberg, MD, MBA
Jennifer, I. Lim, MD, FASRS, FARVO
Ehsan Rahimy, MD
